Drugs / UK-500,001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00263874 | Nov 2005 → Sep 2006 | chronic obstructive pulmonary disease | Pfizer | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UK-500,001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00263874 ↗ |
| Modality | Small molecule | “the compound UK-500,001” PMID 19213793 ↗ Feb 2009 |
| Route | Inhaled | “novel inhaled PDE4 inhibitor” PMID 19213793 ↗ Feb 2009 |